Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 10

1.

Identification and diagnostic performance of a small RNA within the PCA3 and BMCC1 gene locus that potentially targets mRNA.

Drayton RM, Rehman I, Clarke R, Zhao Z, Pang K, Miah S, Stoehr R, Hartmann A, Blizard S, Lavin M, Bryant HE, Martens-Uzunova ES, Jenster G, Hamdy FC, Gardiner RA, Catto JW.

Cancer Epidemiol Biomarkers Prev. 2015 Jan;24(1):268-75. doi: 10.1158/1055-9965.EPI-14-0377. Epub 2014 Nov 12.

2.

Identification of differentially expressed long noncoding RNAs in bladder cancer.

Peter S, Borkowska E, Drayton RM, Rakhit CP, Noon A, Chen W, Catto JW.

Clin Cancer Res. 2014 Oct 15;20(20):5311-21. doi: 10.1158/1078-0432.CCR-14-0706. Epub 2014 Aug 27.

3.

MicroRNA-99a and 100 mediated upregulation of FOXA1 in bladder cancer.

Drayton RM, Peter S, Myers K, Miah S, Dudziec E, Bryant HE, Catto JW.

Oncotarget. 2014 Aug 15;5(15):6375-86.

4.

Reduced expression of miRNA-27a modulates cisplatin resistance in bladder cancer by targeting the cystine/glutamate exchanger SLC7A11.

Drayton RM, Dudziec E, Peter S, Bertz S, Hartmann A, Bryant HE, Catto JW.

Clin Cancer Res. 2014 Apr 1;20(7):1990-2000. doi: 10.1158/1078-0432.CCR-13-2805. Epub 2014 Feb 10.

5.

The role of microRNA in the response to cisplatin treatment.

Drayton RM.

Biochem Soc Trans. 2012 Aug;40(4):821-5. doi: 10.1042/BST20120055. Review.

PMID:
22817741
6.

An evaluation of urinary microRNA reveals a high sensitivity for bladder cancer.

Miah S, Dudziec E, Drayton RM, Zlotta AR, Morgan SL, Rosario DJ, Hamdy FC, Catto JW.

Br J Cancer. 2012 Jun 26;107(1):123-8. doi: 10.1038/bjc.2012.221. Epub 2012 May 29.

7.

Inhibition of poly(ADP-ribose) glycohydrolase (PARG) specifically kills BRCA2-deficient tumor cells.

Fathers C, Drayton RM, Solovieva S, Bryant HE.

Cell Cycle. 2012 Mar 1;11(5):990-7. doi: 10.4161/cc.11.5.19482. Epub 2012 Mar 1.

PMID:
22333589
8.

Molecular mechanisms of cisplatin resistance in bladder cancer.

Drayton RM, Catto JW.

Expert Rev Anticancer Ther. 2012 Feb;12(2):271-81. doi: 10.1586/era.11.201. Review.

PMID:
22316374
9.

The Fanconi anemia pathway is downregulated upon macrophage differentiation through two distinct mechanisms.

Lu WT, Lemonidis K, Drayton RM, Nouspikel T.

Cell Cycle. 2011 Oct 1;10(19):3300-10. doi: 10.4161/cc.10.19.17178. Epub 2011 Oct 1.

PMID:
21926477
10.

Supplemental Content

Loading ...
Support Center